Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review

Abstract

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an exceedingly low median overall survival of only 15 months. Current standard-of-care for GBM consists of gross total surgical resection followed by radiation with concurrent and adjuvant chemotherapy. Temozolomide (TMZ) is the first-choice chemotherapeutic agent in GBM; however, the development of resistance to TMZ often becomes the limiting factor in effective treatment. While O6-methylguanine-DNA methyltransferase repair activity and uniquely resistant populations of glioma stem cells are the most well-known contributors to TMZ resistance, many other molecular mechanisms have come to light in recent years. Key emerging mechanisms include the involvement of other DNA repair systems, aberrant signaling pathways, autophagy, epigenetic modifications, microRNAs, and extracellular vesicle production. This review aims to provide a comprehensive overview of the clinically relevant molecular mechanisms and their extensive interconnections to better inform efforts to combat TMZ resistance.

Keywords

Glioblastoma / temozolomide / chemoresistance / molecular mechanisms

References

[1] Ostrom QT,Gittleman H.CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016..Neuro Oncol2019;21:v1-100 PMCID:PMC6823730

[2] Krex D,Hartmann C.Long-term survival with glioblastoma multiforme..Brain2007;130:2596-606

[3] Johnson DR.Glioblastoma survival in the United States before and during the temozolomide era..J Neurooncol2012;107:359-64

[4] Delgado-Lopez PD.Survival in glioblastoma: a review on the impact of treatment modalities..Clin Transl Oncol2016;18:1062-71

[5] Stupp R,van den Bent MJ.High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up..Ann Oncol.2014;25 Suppl 3:iii93-101

[6] Carter TC,Lawler BE.Glioblastoma treatment with temozolomide and bevacizumab and overall survival in a rural tertiary healthcare practice..Biomed Res Int2018;2018:6204676 PMCID:PMC6330814

[7] Seystahl K,Loew S.Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma..J Cancer Res Clin Oncol2020;146:659-70

[8] Gerstner ER,Chang K.Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma..Clin Cancer Res2020;26:206-12 PMCID:PMC7139851

[9] Champeaux C.Implantation of carmustine wafers (Gliadel ®) for high-grade glioma treatment. A 9-year nationwide retrospective study..J Neurooncol2020;147:159-69

[10] Ashby LS,Stea B.Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review..World J Surg Oncol2016;14:225 PMCID:PMC4997737

[11] Mittal S,Michelhaugh SK.Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies..J Neurosurg2018;128:414-21 PMCID:PMC6836465

[12] Kinzel A,Varshaver M.Tumor treating fields for glioblastoma treatment: patient satisfaction and compliance with the second-generation optune((R)) System..Clin Med Insights Oncol2019;13:1179554918825449 PMCID:PMC6351720

[13] Guberina N,Kebir S.Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial..Radiat Oncol2020;15:83 PMCID:PMC7168823

[14] Stupp R,Kanner A.Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial..JAMA2017;318:2306-16 PMCID:PMC5820703

[15] Fabian D,Alnahhas I.Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review..Cancers (Basel)2019;11:174 PMCID:PMC6406491

[16] Louis DN,Reifenberger G.The 2016 World Health Organization classification of tumors of the central nervous system: a summary..Acta Neuropathol2016;131:803-20

[17] Yang P,Wang Y.IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry..Oncotarget2015;6:40896-906 PMCID:PMC4747376

[18] Le Rhun E,Roth P.Molecular targeted therapy of glioblastoma..Cancer Treat Rev2019;80:101896

[19] Weller M,Reifenberger G.MGMT promoter methylation in malignant gliomas: ready for personalized medicine?.Nat Rev Neurol2010;6:39-51

[20] Hegi ME,Gorlia T.MGMT gene silencing and benefit from temozolomide in glioblastoma..N Engl J Med2005;352:997-1003

[21] Chen R,Cohen AL.Glioma subclassifications and their clinical significance..Neurotherapeutics2017;14:284-97 PMCID:PMC5398991

[22] Arora A.Glioblastoma vs temozolomide: can the red queen race be won?.Cancer Biol Ther2019;20:1083-90 PMCID:PMC6606031

[23] Mohammad SN.Chemical reactivity of a methyldiazonium ion with nucleophilic centers of DNA bases..J Theor Biol1980;87:401-9

[24] Friedman HS,Calvert H.Temozolomide and treatment of malignant glioma..Clin Cancer Res2000;6:2585-97

[25] Stupp R,van den Bent MJ.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma..N Engl J Med2005;352:987-96

[26] Lee SY.Temozolomide resistance in glioblastoma multiforme..Genes Dis2016;3:198-210 PMCID:PMC6150109

[27] Wick W.Understanding and targeting alkylator resistance in glioblastoma..Cancer Discov2014;4:1120-2

[28] Xie Q,Berens ME.Targeting adaptive glioblastoma: an overview of proliferation and invasion..Neuro Oncol2014;16:1575-84 PMCID:PMC4232088

[29] Ignatova TN,Laywell ED.Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro..Glia2002;39:193-206

[30] Chen J,Yu TS.A restricted cell population propagates glioblastoma growth after chemotherapy..Nature2012;488:522-6 PMCID:PMC3427400

[31] Bao S,McLendon RE.Glioma stem cells promote radioresistance by preferential activation of the DNA damage response..Nature2006;444:756-60

[32] Hassn Mesrati M,Abuhamad AY.Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer..Cells2020;9:1236 PMCID:PMC7291262

[33] Kim H,Amini SS.Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution..Genome Res2015;25:316-27 PMCID:PMC4352879

[34] Orzan F,Crisafulli G.Genetic evolution of glioblastoma stem-like cells from primary to recurrent tumor..Stem Cells2017;35:2218-28

[35] Garnier D,Kislinger T.Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization..Neuro Oncol2018;20:236-48 PMCID:PMC5777501

[36] Lan X,Cavalli FMG.Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy..Nature2017;549:227-32 PMCID:PMC5608080

[37] Cordner R,Wheeler CJ.Exploitation of adaptive evolution in glioma treatment..CNS Oncol2013;2:171-9 PMCID:PMC3746825

[38] Feldheim J,Monoranu CM.Changes of O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation in glioblastoma relapse-a meta-analysis type literature review..Cancers (Basel)2019;11: PMCID:PMC6966671

[39] Rivera AL,Gilbert MR.MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma..Neuro Oncol2010;12:116-21 PMCID:PMC2940581

[40] Park CK,Kim JY.The changes in MGMT promoter methylation status in initial and recurrent glioblastomas..Transl Oncol2012;5:393-7 PMCID:PMC3468928

[41] Herrlinger U,Mack F.Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial..Lancet2019;393:678-88

[42] Tang JB,Trivedi RN.N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide..Neuro Oncol2011;13:471-86 PMCID:PMC3093332

[43] Trivedi RN,Fornsaglio JL,Sobol RW.The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death..Cancer Res2005;65:6394-400

[44] Agnihotri S,Buczkowicz P.ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents..Cancer Discov2014;4:1198-213 PMCID:PMC4184920

[45] Thanasupawat T,Rommel A,Bergen H.Dovitinib enhances temozolomide efficacy in glioblastoma cells..Mol Oncol2017;11:1078-98 PMCID:PMC5537714

[46] Parsons JL,Allinson SL.Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts..FEBS J2005;272:2012-21

[47] Woodhouse BC,Parsons JL.Poly(ADP-ribose) polymerase-1 modulates DNA repair capacity and prevents formation of DNA double strand breaks..DNA Repair (Amst)2008;7:932-40

[48] Nakada M,Hayashi Y,Hamada J.The strategy for enhancing temozolomide against malignant glioma..Front Oncol2012;2:98 PMCID:PMC3418701

[49] Atkins RJ,Stylli SS,Kaye AH.Repair mechanisms help glioblastoma resist treatment..J Clin Neurosci2015;22:14-20

[50] Gil Del Alcazar CR,Habib AA,Burma S.Augmented HR repair mediates acquired temozolomide resistance in glioblastoma..Mol Cancer Res2016;14:928-40 PMCID:PMC5065752

[51] Messaoudi K,Lagarce F.Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide..Drug Discov Today2015;20:899-905

[52] Erasimus H,Niclou S.DNA repair mechanisms and their clinical impact in glioblastoma..Mutat Res Rev Mutat Res2016;769:19-35

[53] Yoshimoto K,Hata N.Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma..Front Oncol2012;2:186 PMCID:PMC3514620

[54] Zhang J,Bradshaw TD.Temozolomide: mechanisms of action, repair and resistance..Curr Mol Pharmacol2012;5:102-14

[55] Touat M,Boynton AN.Mechanisms and therapeutic implications of hypermutation in gliomas..Nature2020;580:517-23

[56] Perazzoli G,Ortiz R.Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-Glycoprotein and CD133 expression..PLoS One2015;10:e0140131 PMCID:PMC4598115

[57] Stark AM,Hugo HH.Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma..Neurol Res2015;37:95-105

[58] Indraccolo S,Fassan M.Genetic, epigenetic, and immunologic profiling of MMR-deficient relapsed glioblastoma..Clin Cancer Res2019;25:1828-37

[59] Nagel ZD,Gupta SK.DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme..Cancer Res2017;77:198-206 PMCID:PMC6100738

[60] Struve N,Stead LF.EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma..Oncogene2020;39:3041-55 PMCID:PMC7142016

[61] Guo G,Hong R.IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma..Clin Transl Oncol2020;22:1252-62

[62] Harder BG,Sereduk CP.Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells..Mol Med2019;25:49 PMCID:PMC6854621

[63] Pearson JRD.Targeting cellular pathways in glioblastoma multiforme..Signal Transduct Target Ther2017;2:17040 PMCID:PMC5661637

[64] Network CGAR.Comprehensive genomic characterization defines human glioblastoma genes and core pathways..Nature2008;455:1061-8 PMCID:PMC2671642

[65] Westphal M,Lamszus K.EGFR as a target for glioblastoma treatment: an unfulfilled promise..CNS Drugs2017;31:723-35 PMCID:PMC5573763

[66] Taylor TE,Cavenee WK.Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance..Curr Cancer Drug Targets2012;12:197-209 PMCID:PMC3464093

[67] Zhou J,Frank R.PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation..J Biol Chem2004;279:13506-13

[68] Zheng HC.The molecular mechanisms of chemoresistance in cancers..Oncotarget2017;8:59950-64 PMCID:PMC5601792

[69] Velpula KK,Sahu K.Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma..Oncotarget2017;8:35639-55 PMCID:PMC5482605

[70] Hitosugi T,Chung TW.Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism..Mol Cell2011;44:864-77 PMCID:PMC3246218

[71] Velpula KK,Asuthkar S.Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect..Cancer Res2013;73:7277-89

[72] Velpula KK.PDK1: a new therapeutic target for glioblastoma?.CNS Oncol2014;3:177-9 PMCID:PMC6124368

[73] Azuaje F,Niclou SP.Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma..Cell Commun Signal2015;13:23 PMCID:PMC4391485

[74] Wang H,Jiang Y.The challenges and the promise of molecular targeted therapy in malignant gliomas..Neoplasia2015;17:239-55 PMCID:PMC4372648

[75] Franovic A,Smith K.Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer..Proc Natl Acad Sci U S A2007;104:13092-7 PMCID:PMC1941796

[76] Muñoz-Pinedo C,Ricci JE.Cancer metabolism: current perspectives and future directions..Cell Death Dis2012;3:e248 PMCID:PMC3270265

[77] Plathow C.Tumor cell metabolism imaging..J Nucl Med.2008;49 Suppl 2:43S-63

[78] Steiner HH,Mueller MM.Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels..J Neurooncol2004;66:129-38

[79] Joensuu H,Sihto H,Nupponen NN.Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme..J Pathol2005;207:224-31

[80] Weathers SP.VEGF manipulation in glioblastoma..Oncology (Williston Park)2015;29:720-7

[81] Wurth R,Harrison JK,Florio T.CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment..Front Cell Neurosci2014;8:144 PMCID:PMC4036438

[82] Wang S,Li J.The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1..J Neurol Sci2020;414:116837

[83] Sunayama J,Matsuda K.FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity..Stem Cells2011;29:1327-37

[84] Shi J,Shen A.Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1..J Neurooncol2010;98:57-69

[85] Qian Z,Wu D.Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis..Int J Cancer2017;140:2792-804

[86] Bai D,Vogt PK.Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt..Int J Cancer2009;125:2863-70 PMCID:PMC2767458

[87] Nogueira L,Vazquez-Barquero A,Fernandez-Luna JL.The NFkappaB pathway: a therapeutic target in glioblastoma..Oncotarget2011;2:646-53 PMCID:PMC3248209

[88] Fu Z.FOXOs, cancer and regulation of apoptosis..Oncogene2008;27:2312-9 PMCID:PMC2819403

[89] Zhang X,Hadden TJ.Akt, FoxO and regulation of apoptosis..Biochim Biophys Acta2011;1813:1978-86

[90] Salvesen GS.IAP proteins: blocking the road to death’s door..Nat Rev Mol Cell Biol2002;3:401-10

[91] Song Z,Ling G.Escape of U251 glioma cells from temozolomide-induced senescence was modulated by CDK1/survivin signaling..Am J Transl Res2017;9:2163-80 PMCID:PMC5446501

[92] Tompa M,Nagy A.Contribution of the Wnt pathway to defining biology of glioblastoma..Neuromolecular Med2018;20:437-51

[93] Riganti C,Caldera V.Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/beta-catenin pathway..Neuro Oncol2013;15:1502-17 PMCID:PMC3813413

[94] Lan F,Yu H.Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/beta-catenin signaling in glioblastoma..J Neurochem2015;134:811-8

[95] Lu J,Zhao D.ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of beta-catenin via up-regulation of Axin..J Neurooncol2008;87:271-7

[96] Xu K,Pei H.FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of beta-catenin nuclear accumulation..Oncol Rep2017;37:2391-7

[97] Morris LG,Gong Y.Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation..Nat Genet2013;45:253-61 PMCID:PMC3729040

[98] Kamino M,Kibe T.Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2..Cancer Sci2011;102:540-8

[99] Skoda J,Loja T.Co-expression of cancer stem cell markers corresponds to a pro-tumorigenic expression profile in pancreatic adenocarcinoma..PLoS One2016;11:e0159255 PMCID:PMC4945008

[100] Fu Y,An N.beta-catenin as a potential key target for tumor suppression..Int J Cancer2011;129:1541-51

[101] Valenta T,Basler K.The many faces and functions of beta-catenin..EMBO J2012;31:2714-36 PMCID:PMC3380220

[102] Zhang M,Rosen JM.Selective targeting of radiation-resistant tumor-initiating cells..Proc Natl Acad Sci U S A2010;107:3522-7 PMCID:PMC2840501

[103] Kahlert UD,Doostkam S,Simons B.Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition..Cancer Lett2012;325:42-53

[104] Huang M,Wu JY.Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma..Sci Transl Med2020;12:eaay7522 PMCID:PMC7261487

[105] Liao H,Qiu S.MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2..Oncotarget2015;6:8914-28 PMCID:PMC4496192

[106] Zhang N,Gong A.FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis..Cancer Cell2011;20:427-42 PMCID:PMC3199318

[107] Zheng H,Wiedemeyer R.PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas..Cancer Cell2010;17:497-509 PMCID:PMC2900858

[108] Sandberg CJ,Jeong J.Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome..Exp Cell Res2013;319:2230-43

[109] Garg M.Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer..World J Stem Cells2013;5:188-95 PMCID:PMC3812522

[110] Bhuvanalakshmi G,Millward M,Warrier S.Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties..PLoS One2015;10:e0127517 PMCID:PMC4452329

[111] Wickstrom M,Milosevic J.Wnt/beta-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance..Nat Commun2015;6:8904 PMCID:PMC4674781

[112] Tomar VS,Somasundaram K.Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy..Cell Biol Toxicol2020;36:273-8

[113] Lu C,Liu B.FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling..Neurosci Lett2017;657:77-83

[114] Luo W,Song Z.miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/beta-catenin signaling via targeting SOX2..Life Sci2019;226:98-106

[115] Zeng A,Li Y.miR-129-5p targets Wnt5a to block PKC/ERK/NF-kappaB and JNK pathways in glioblastoma..Cell Death Dis2018;9:394 PMCID:PMC5847604

[116] Ujifuku K,Takakura S.miR-195, miR-455-3p and miR-10a (*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells..Cancer Lett2010;296:241-8

[117] Zhang KL,Chen LY.Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas..Cancer Lett2014;342:139-49

[118] Huang T,Pangeni RP.A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways..Nat Commun2016;7:12885 PMCID:PMC5059456

[119] Chen KC,Ho KH.IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/beta-catenin pathway..PLoS One2019;14:e0225913 PMCID:PMC6894868

[120] Segerman A,Haglund C.Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition..Cell Rep2016;17:2994-3009

[121] Jahani-Asl A,Soleimani VD.Control of glioblastoma tumorigenesis by feed-forward cytokine signaling..Nat Neurosci2016;19:798-806 PMCID:PMC4984527

[122] Kim E,Woo DH.Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells..Cancer Cell2013;23:839-52 PMCID:PMC4109796

[123] Zhou J,Ouyang Q.Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway..Cell Signal2014;26:2896-902

[124] Swiatek-Machado K.STAT signaling in glioma cells..Adv Exp Med Biol2020;1202:203-22

[125] Lo HW,Zhu H.Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators..Clin Cancer Res2008;14:6042-54 PMCID:PMC2707832

[126] Krasilnikov M,Dong J.ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis..Oncogene2003;22:4092-101

[127] Lu Y,Xu C.JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes..Cell Physiol Biochem2008;21:305-14

[128] Sharfe N,Roifman CM.JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3’ kinase..Blood1995;86:2077-85

[129] Kohsaka S,Yachi K.STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression..Mol Cancer Ther2012;11:1289-99

[130] Dai B,Peyton M.STAT3 mediates resistance to MEK inhibitor through microRNA miR-17..Cancer Res2011;71:3658-68 PMCID:PMC3392199

[131] Xu H,Zhang Y.Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner..BMC Cancer2014;14:330 PMCID:PMC4024187

[132] Wang Y,Bao Z.Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways..Oncol Rep2011;26:1173-80

[133] Lee HH,Lin HY.Histone 2A family member j drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme..Cancers (Basel)2019;12:98 PMCID:PMC7016639

[134] Caja L,Dadras MS.Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells..Oncogene2018;37:2515-31 PMCID:PMC5945579

[135] Liang H,Li J.Snail expression contributes to temozolomide resistance in glioblastoma..Am J Transl Res2019;11:4277-89 PMCID:PMC6684932

[136] Cui P,Hou J.STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction..Cell Signal2020;71:109598

[137] Nazio F,Cianfanelli V,Cecconi F.Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications..Cell Death Differ2019;26:690-702 PMCID:PMC6460398

[138] Jiapaer S,Tanaka S,Nakada M.Potential strategies overcoming the temozolomide resistance for glioblastoma..Neurol Med Chir (Tokyo)2018;58:405-21 PMCID:PMC6186761

[139] Klionsky DJ.Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins..Nat Struct Mol Biol2014;21:336-45 PMCID:PMC4036234

[140] He Y,Lan B,Zhao J.Targeting off-target effects: endoplasmic reticulum stress and autophagy as effective strategies to enhance temozolomide treatment..Onco Targets Ther2019;12:1857-65 PMCID:PMC6413742

[141] Paglin S,Delohery T.A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles..Cancer Res2001;61:439-44

[142] Sui X,Wang Z.Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment..Cell Death Dis2013;4:e838 PMCID:PMC3824660

[143] Kanzawa T,Komata T.Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells..Cell Death Differ2004;11:448-57

[144] Carmo A,Crespo I,Lopes MC.Effect of temozolomide on the U-118 glioma cell line..Oncol Lett2011;2:1165-70 PMCID:PMC3406512

[145] Hombach-Klonisch S,Shojaei S.Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response..Pharmacol Ther2018;184:13-41

[146] Lin CJ,Shih YL.Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy..Free Radic Biol Med2012;52:377-91

[147] Chen CM,Way TD.BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide..Int J Mol Med2015;36:1244-52 PMCID:PMC4601748

[148] Filippi-Chiela EC,Thome MP.Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage..Autophagy2015;11:1099-113 PMCID:PMC4590630

[149] Zou Y,Wang W.MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangiectasia mutated in glioma..Mol Med Rep2015;11:4591-6

[150] Sano R.ER stress-induced cell death mechanisms..Biochim Biophys Acta2013;1833:3460-70 PMCID:PMC3834229

[151] Golden EB,Jahanian A.Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy..Neurosurg Focus2014;37:E12

[152] Zanotto-Filho A,Klafke K.Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas..Cancer Lett2015;358:220-31

[153] Wen ZP,Chen YH.Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux..J Exp Clin Cancer Res2019;38:298 PMCID:PMC6617611

[154] Amaravadi RK.The roles of therapy-induced autophagy and necrosis in cancer treatment..Clin Cancer Res2007;13:7271-9

[155] Deegan S,Logue SE.Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions..Autophagy2014;10:1921-36 PMCID:PMC4502706

[156] Zhang YB,Zeng RX.Autophagic degradation of caspase-8 protects U87MG cells against H2O2-induced oxidative stress..Asian Pac J Cancer Prev2013;14:4095-9

[157] Ye F,Liu Y.Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence..PLoS One2013;8:e80397 PMCID:PMC3832364

[158] Knizhnik AV,Nikolova T.Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage..PLoS One2013;8:e55665 PMCID:PMC3559438

[159] Johannessen TC,Zhu H.Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide..Int J Cancer2019;144:1735-45

[160] Josset E,Noel G.The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line..Anticancer Res2013;33:1845-51

[161] Liu T,Xu Y.Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition..Oncol Rep2019;41:1883-92

[162] Li C,Liu H.Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells..Cell Physiol Biochem2015;35:1303-16

[163] Kim EL,Rubsam A.Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells..Neuro Oncol2010;12:389-400 PMCID:PMC2940600

[164] Rosenfeld MR,Supko JG.A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme..Autophagy2014;10:1359-68 PMCID:PMC4203513

[165] Shao CJ,Chen FR.Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines in vitro..Chin Med J (Engl)2012;125:4338-43

[166] Lohitesh K,Srivastava A.Autophagy inhibition potentiates SAHAmediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria..Oncol Rep2018;39:2787-96

[167] Russell RC,Yuan H.ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase..Nat Cell Biol2013;15:741-50 PMCID:PMC3885611

[168] Stjepanovic G,Lin MG.Vps34 kinase domain dynamics regulate the autophagic PI 3-kinase complex..Mol Cell2017;67:528-34.e3 PMCID:PMC5573195

[169] Chu CW,Chou CH.Thioridazine enhances P62-mediated autophagy and apoptosis through wnt/beta-catenin signaling pathway in glioma cells..Int J Mol Sci2019;20: PMCID:PMC6386927

[170] Yang MC,Li YY.Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma..Int J Oncol2015;46:1304-16

[171] Scarfo L.Reprogramming cell death: BCL2 family inhibition in hematological malignancies..Immunol Lett2013;155:36-9

[172] Yan Y,Dai S.Targeting autophagy to sensitive glioma to temozolomide treatment..J Exp Clin Cancer Res2016;35:23 PMCID:PMC4736617

[173] Torres S,Rodriguez-Fornes F.A combined preclinical therapy of cannabinoids and temozolomide against glioma..Mol Cancer Ther2011;10:90-103

[174] Ulasov IV,Nandi S.Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo..Br J Cancer2009;100:1154-64 PMCID:PMC2664399

[175] Lin CJ,Shih YL.Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells..PLoS One2012;7:e38706 PMCID:PMC3382156

[176] Seto E.Erasers of histone acetylation: the histone deacetylase enzymes..Cold Spring Harb Perspect Biol2014;6:a018713 PMCID:PMC3970420

[177] Xu WS,Marks PA.Histone deacetylase inhibitors: molecular mechanisms of action..Oncogene2007;26:5541-52

[178] Gregoretti IV,Goodson HV.Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis..J Mol Biol2004;338:17-31

[179] Ropero S.The role of histone deacetylases (HDACs) in human cancer..Mol Oncol2007;1:19-25 PMCID:PMC5543853

[180] Zhao LM.Histone deacetylase inhibitors in tumor immunotherapy..Curr Med Chem2019;26:2990-3008

[181] Sun Y,Yue S,Lu F.Histone deacetylase inhibitors in cancer therapy..Curr Top Med Chem2018;18:2420-8

[182] Bolden JE,Johnstone RW.Anticancer activities of histone deacetylase inhibitors..Nat Rev Drug Discov2006;5:769-84

[183] Carew JS,Nawrocki ST.Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy..Cancer Lett2008;269:7-17

[184] Bezecny P.Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience..Med Oncol2014;31:985

[185] Yelton CJ.Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma..Neuroimmunol Neuroinflamm2018;5:46 PMCID:PMC6348296

[186] Lee DH,Won HR.Advances in epigenetic glioblastoma therapy..Oncotarget2017;8:18577-89 PMCID:PMC5392350

[187] Staberg M,Rasmussen RD.Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine..Cell Oncol (Dordr)2017;40:21-32

[188] Li S,Mao L.Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways..Brain Res2018;1692:154-62

[189] Liu JR,Hung PY,Chern JW.High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma..Biochem Pharmacol2019;163:458-71

[190] Santos-Barriopedro I,Bahl S.HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1..Genes Cancer2019;10:119-33 PMCID:PMC6872666

[191] Kim GW,Yeon SK.Temozolomide-resistant glioblastoma depends on HDAC6 activity through regulation of DNA mismatch repair..Anticancer Res2019;39:6731-41

[192] Li ZY,Chen L.Histone deacetylase inhibitor RGFP109 overcomes temozolomide resistance by blocking NF-kappaB-dependent transcription in glioblastoma cell lines..Neurochem Res2016;41:3192-205

[193] Luo JW,Yang Y.Role of micro-RNA (miRNA) in pathogenesis of glioblastoma..Eur Rev Med Pharmacol Sci2015;19:1630-9

[194] Novakova J,Vyzula R.MicroRNA involvement in glioblastoma pathogenesis..Biochem Biophys Res Commun2009;386:1-5

[195] Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function..Cell2004;116:281-97

[196] Kirstein A,Combs SE.The role of miRNA for the treatment of MGMT unmethylated glioblastoma multiforme..Cancers (Basel)2020;12:1099 PMCID:PMC7281574

[197] Mizoguchi M,Yoshimoto K.Clinical implications of microRNAs in human glioblastoma..Front Oncol2013;3:19 PMCID:PMC3566410

[198] Sarkar S,Mittal S.The therapeutic role of microRNAs in human gliomas. MicroRNA Targeted Cancer Therapy.2014;DordrechtSpringer1-27

[199] Mathupala SP,Guthikonda M.MicroRNA and brain tumors: a cause and a cure?.DNA Cell Biol2007;26:301-10 PMCID:PMC3385864

[200] Mathupala S,Guthikonda M.RNAi-based approaches to the treatment of brain tumors. MicroRNAs in cancer translational research.2011;New YorkSpringer533-49

[201] Shi L,Yang J.MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity..Brain Res2010;1352:255-64

[202] Zhang S,Pan T.MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide..J Mol Neurosci2012;47:346-56

[203] Zhou RJ,Liu BX.Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells..Int J Mol Med2015;36:1159-64

[204] Chen J,Wan Y.miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1..Tumour Biol2014;35:6293-302

[205] Haemmig S,Gluck A.miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas..Cell Death Dis2014;5:e1279 PMCID:PMC4611719

[206] Shi L,Feng K.MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis..Int J Oncol2012;40:119-29

[207] Shi L,Sun G.miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3..BioDrugs2014;28:41-54

[208] Chen H,Li W.miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase..J Transl Med2015;13:69 PMCID:PMC4345002

[209] Zhang HD,Sun DW,Ji ZL.The role of miR-130a in cancer..Breast Cancer2017;24:521-7

[210] Wong ST,Zhuang JT.MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells..Anticancer Res2012;32:2835-41

[211] Chen L,Han L.Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status..Oncol Rep2012;27:854-60

[212] Brognara E,Montagner G.High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222..Int J Oncol2016;48:1029-38

[213] Quintavalle C,Roscigno G.MiR-221/222 target the DNA methyltransferase MGMT in glioma cells..PLoS One2013;8:e74466 PMCID:PMC3798259

[214] She X,Cui Y.miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma..Oncol Rep2014;32:957-64

[215] Lee D,Zhang XQ.MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma..J Cancer2015;6:227-32 PMCID:PMC4317757

[216] Chen G,Zhao H.MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1..J Cell Mol Med2020;24:5363-74 PMCID:PMC7205810

[217] Lee YY,Wang ML.MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells..Cancer Manag Res2018;10:775-85 PMCID:PMC5903834

[218] Chiou GY,Wang ML.Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma..Mol Cell2013;52:693-706

[219] Zhang W,Hoadley K.miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression..Neuro Oncol2012;14:712-9 PMCID:PMC3367855

[220] Nadaradjane A,Bougras-Cartron G.miR-370-3p is a therapeutic tool in anti-glioblastoma therapy but is not an intratumoral or cell-free circulating biomarker..Mol Ther Nucleic Acids2018;13:642-50 PMCID:PMC6258828

[221] Gao YT,Liu HL.Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression..Sci Rep2016;6:32972 PMCID:PMC5011744

[222] Khalil S,Santangelo A.miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma..Oncotarget2016;7:28195-206 PMCID:PMC5053720

[223] Kushwaha D,Ng K.A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas..Oncotarget2014;5:4026-39 PMCID:PMC4147303

[224] Kreth S,Hinske LC.In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing..Acta Neuropathol2013;125:671-81

[225] Ren Y,Mei M.MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol..BMC Cancer2010;10:27 PMCID:PMC2824710

[226] Zhang S,Wei J.Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes..Int J Oncol2015;46:1589-600

[227] Barker CA,Chou JF.Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma..J Neurooncol2012;109:391-7 PMCID:PMC4712045

[228] Costa PM,Nobrega C.MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma..Hum Mol Genet2013;22:904-18 PMCID:PMC3561912

[229] Li Y,Yang Y.MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme..Brain Res2009;1286:13-8

[230] Wang Z,Fu Y,Tian Y.MiRNA-130a-3p inhibits cell proliferation, migration, and TMZ resistance in glioblastoma by targeting Sp1..Am J Transl Res2019;11:7272-85 PMCID:PMC6943444

[231] Tan Z,Jiang Y.MiR-150-3p targets SP1 and suppresses the growth of glioma cells..Biosci Rep2018;38: PMCID:PMC6048207

[232] Chuang JY,Ko CY.Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma..Oncogenesis2017;6:e339 PMCID:PMC5523064

[233] Yang YN,Wang YM,Gu Z.miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-alpha in glioblastoma..Oncol Lett2018;15:7563-70 PMCID:PMC5920462

[234] Shea A,Afzal Z.MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics..Cancer Med2016;5:1917-46 PMCID:PMC4971921

[235] Comincini S,Palumbo S.microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells..Cancer Biol Ther2013;14:574-86 PMCID:PMC3742487

[236] Namee NM.Extracellular vesicles and anti-cancer drug resistance..Biochim Biophys Acta Rev Cancer2018;1870:123-36

[237] Saadatpour L,Fadaei S.Glioblastoma: exosome and microRNA as novel diagnosis biomarkers..Cancer Gene Ther2016;23:415-8

[238] D’Asti E,Lee TH.Extracellular vesicles in brain tumor progression..Cell Mol Neurobiol2016;36:383-407

[239] Gourlay J,Luwor RB.The emergent role of exosomes in glioma..J Clin Neurosci2017;35:13-23

[240] Zeng A,Yan W.Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma..Cancer Lett2018;436:10-21

[241] Zhang Z,Lu C.Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma..J Exp Clin Cancer Res2019;38:166 PMCID:PMC6469146

[242] Basu B.Extracellular vesicles in glioma: from diagnosis to therapy..Bioessays2019;41:e1800245

[243] Zeng AL,Liu YW.Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma..Oncogene2017;36:5369-81 PMCID:PMC5611480

[244] Kore RA,Jenkins SV.Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells..Biochem Biophys Rep2018;14:104-13 PMCID:PMC5986551

[245] Akers JC,Kim R.MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development..PLoS One2013;8:e78115 PMCID:PMC3804457

[246] Shao H,Lee K.Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma..Nat Commun2015;6:6999 PMCID:PMC4430127

[247] Yekula A,Beecroft A.The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas..Cancer Drug Resist2020;3:[Online First]. doi: 10.20517/cdr.2020.61